Corporate Board Profile
| Filing Date | Source Excerpt |
|---|---|
| 2015-12-18 | Dr. Hrynkow was selected as a director for her organizational leadership and management as well as her global networking experience. |
| 2016-12-14 | Dr. Hrynkow was selected as a director for her organizational leadership and management as well as her global networking experience. |
| 2021-12-30 | Dr. Sharon Hrynkow is Chief Scientific Officer and Senior VP for Medical Affairs at Cyclo Therapeutics (Nasdaq: CYTH) where she has led drug development programs since 2015. |
| 2022-12-19 | Dr. Sharon Hrynkow, a neuroscientist by training, is Founder and Managing Partner of Global Health Consulting, LLC, an advisory group assisting clients on federal funding opportunities and strategies to grow biomedical companies. |
| 2024-01-02 | Dr. Sharon Hrynkow is Founder and Managing Partner of Global Health Consulting, LLC, an advisory group assisting clients on federal funding opportunities and strategies to grow life science companies. |
Data sourced from SEC filings. Last updated: 2025-04-15